about
Challenges and Opportunities for T-Cell-Mediated Strategies to Eliminate HIV ReservoirsCan immunotherapy be useful as a "functional cure" for infection with Human Immunodeficiency Virus-1?Towards an HIV cure based on targeted killing of infected cells: different approaches against acute versus chronic infectionSystems-level analysis of innate immunity.A correlate of HIV-1 control consisting of both innate and adaptive immune parameters best predicts viral load by multivariable analysis in HIV-1 infected viremic controllers and chronically-infected non-controllersImmune interventions in HIV infection.Autophagy plays an important role in the containment of HIV-1 in nonprogressor-infected patients.CD4+ T cell depletion in human immunodeficiency virus (HIV) infection: role of apoptosis.Dissecting the dynamics of HIV-1 protein sequence diversity.Distinct tryptophan catabolism and Th17/Treg balance in HIV progressors and elite controllers.Raltegravir in HIV-1 infection: Safety and Efficacy in Treatment-naïve Patients.Interplay between HIV-1 and Host Genetic Variation: A Snapshot into Its Impact on AIDS and Therapy Response.The Breadth of Expandable Memory CD8+ T Cells Inversely Correlates with Residual Viral Loads in HIV Elite Controllers.Impact of a decade of successful antiretroviral therapy initiated at HIV-1 seroconversion on blood and rectal reservoirs.The Immune Fulcrum: Regulatory T Cells Tip the Balance Between Pro- and Anti-inflammatory Outcomes upon InfectionCan We Repurpose FDA-Approved Alefacept to Diminish the HIV Reservoir?Therapeutic vaccination expands and improves the function of the HIV-specific memory T-cell repertoire.HIV-1 transcription and latency: an update.How to best measure HIV reservoirs?Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers.HIV-1 Trans Infection of CD4(+) T Cells by Professional Antigen Presenting CellsThe interplay between the X-DING-CD4, IFN-α and IL-8 gene activity in quiescent and mitogen- or HIV-1-exposed PBMCs from HIV-1 elite controllers, AIDS progressors and HIV-negative controls.An evaluation of HIV elite controller definitions within a large seroconverter cohort collaborationIs cure of HIV infection in sight?Eliminating the HIV reservoir.Attacking the HIV reservoir from the immune and viral perspective.A cure for HIV: is it in sight?Gene therapy for HIV infection.Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure.Toward a cure for HIV--Seeking effective therapeutic vaccine strategies.Justification for the inclusion of Gag in HIV vaccine candidates.HIV infection en route to endogenization: two casesIncreased expression of SAMHD1 in a subset of HIV-1 elite controllers.Antiretroviral therapy in the elite controller: justified or premature?Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts.Effects of Mutations on Replicative Fitness and Major Histocompatibility Complex Class I Binding Affinity Are Among the Determinants Underlying Cytotoxic-T-Lymphocyte Escape of HIV-1 Gag Epitopes.Peripheral T follicular helper Cells Make a Difference in HIV Reservoir Size between Elite Controllers and Patients on Successful cART.Role of APOBEC3H in the Viral Control of HIV Elite Controller Patients.What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSM.The B-Cell Follicle in HIV Infection: Barrier to a Cure.
P2860
Q26781511-6E3EB399-3DD0-49B3-A517-2AD2D0EE5191Q26865388-76706504-AA96-40BA-9651-EEB6E31A8DB4Q27005830-DEB43BCF-4709-4F3F-824E-773551098498Q33855179-3BFFEE74-572E-40B9-B23F-AC527BB4BBC6Q33982102-60790FD2-F07E-4246-843E-0A2CEDE0E2A2Q34351326-5FC2200B-A3C7-4900-84FF-61CEB6653093Q34373059-5CB4D080-0BB2-4BEF-A2CD-6CEDA13E98D5Q34633003-B7B7383B-E853-47F9-A4A6-92757885A9CEQ34672589-CA83E12A-B76B-4AB8-A47D-B100EC759A4BQ35023537-C8E2B7FA-6E56-4E40-94F6-7FF4F7689CBAQ35789343-A9DC199E-8474-4BF3-97BE-B453225FBC40Q35993707-BB125754-3FF8-4266-9BFA-51D001A8AFBEQ36208223-AB5CC107-F956-41A8-8243-3151EAB9A4AFQ36311695-9268A83C-8783-41DF-AE18-7997BE423452Q36625426-422D94C1-8BF3-4C49-9FC2-A93F880EC8EAQ36827134-C02D7496-069D-435B-AEB7-ED2B17C310CEQ36846254-39E95AD1-2997-4CF9-8684-397CF27A0528Q36976156-AA853D3E-38D8-403E-BD44-FE10BCD22785Q37149147-37914FAB-B2E3-4EE8-BF98-224D1DEFA220Q37260482-FD0F17D2-FE32-4251-8297-482C3FC3C624Q37287774-DE38A93B-10A8-415F-A19C-DF5DE3D8D827Q37445803-1385B32B-AE45-41E9-B3F4-0A22A572F453Q37525462-AB73FB9C-CB6D-4953-A515-B2B890B46F34Q37690804-7B57494D-FF18-43E5-8D93-11D0D1B11BA2Q37993454-F5D4F363-1113-490D-9123-BC5213802559Q38067646-3C8120F5-2399-4F6C-946F-95D651A0EAE8Q38205472-C6D8CEFC-8EE3-4577-A06C-32A56FB12202Q38260902-0ABC0BD7-2A8B-4DC5-BBAA-12B50696AFC1Q38351585-78D9516A-9A3A-4E1E-A6B1-172E5F135498Q38626469-FBC76251-3922-44E1-AD54-95B84A55951BQ38662319-C51BDF4A-76CE-44EA-B7B4-F2DBA275CAC5Q41679184-30B26431-D2E7-46CE-AD09-6D26AD93892FQ42203657-EB120406-1FF3-427A-8607-C681810BD081Q44462394-8D7E95AF-E08F-40D8-A845-F8F8101512ABQ45930474-5A5C183A-F3E0-47BC-B3AA-A93B86309326Q46652739-4A50FBD1-C72B-402B-815A-A3E2BB59CCEBQ47150484-74D93021-E24B-423F-AE52-2C030C6E3E94Q47553808-98BC3638-09E3-412A-9237-2A0C502AC311Q47561102-58049424-AB83-4E03-A046-349500BAB2DCQ48505361-36A9FB89-0CF7-4DE5-A769-267FF819E57E
P2860
description
article científic
@ca
article scientifique (publié 2011)
@fr
articolo scientifico
@it
artigo científico (publicado na 2011)
@pt
artigo científico (publicado na 2011)
@pt-br
artículo académico publicado el 1 de mayo de 2011
@es
bilimsel makale
@tr
scientific article published on May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
name
Elite controllers as a model of functional cure.
@en
Elite controllers as a model of functional cure.
@nl
type
label
Elite controllers as a model of functional cure.
@en
Elite controllers as a model of functional cure.
@nl
prefLabel
Elite controllers as a model of functional cure.
@en
Elite controllers as a model of functional cure.
@nl
P50
P1476
Elite controllers as a model of functional cure.
@en
P2093
Benjamin Descours
Véronique Avettand-Fenoel
P304
P356
10.1097/COH.0B013E328345A328
P577
2011-05-01T00:00:00Z